Arkolith/Insider Trading/ZNTL/Form 4

Epperly Melissa B,

Chief Financial OfficerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Oct 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$107K
Net Open-Market Flow
-$107K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2023Sell(S)888$19.91$18K388K
Oct 4, 2023Sell(S)5K$19.43$89K389K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001725160-23-000179) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML